logo
  

GSK Gets FDA Approval For Its Measles, Mumps And Rubella Vaccine 'Priorix'

GSK plc (GSK.L) on Monday said, its Measles, Mumps and Rubella (MMR) vaccine, Priorix for individuals 12 months of age and older has been approved by the U.S Food and Drug Administration (FDA).

Priorix is approved to administer as a first dose, followed by a second dose, or as a second dose to people who received another MMR-containing vaccine.

Measles, mumps and rubella are highly contagious viral diseases.

The safety of Priorix was evaluated in six studies with 12,151 participants, who received at least one dose of the vaccine. The most commonly reported adverse reactions were pain, redness, swelling, loss of appetite, irritability, drowsiness and fever.

The vaccine is scheduled to be on the agenda for the June CDC (US Centers for Disease Control and Prevention) Advisory Committee on Immunization Practices (ACIP) meeting for consideration of formal inclusion into the vaccine schedule and recommendations, GSK added.

Priorix is currently licenced in more than 100 countries worldwide, including all European countries, Canada, Australia and New Zealand, GSK said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sysco Corp. (SYY) Tuesday reported a more than a three-times surge in fourth-quarter earnings, supported by 17.5 percent growth in sales. The company projects fiscal 2023 adjusted earnings to grow. Earnings for the quarter spiked to $509.99 million from $151.09 million last year. On a per share basis,... Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly...
Follow RTT